AllCiv
Nonpartisan civic news and tools to power self-government.
Visit allciv.com →Working across liberal democratic institutions, scientific knowledge, value systems, and creative projects.
Nonpartisan civic news and tools to power self-government.
Visit allciv.com →
Professional news, data, and analytics covering Congress, State legislatures, and elections.
Visit legis1.com →
Explore, publish, and peer review science.
Visit allsci.com →
Original music about the US Congress. Debut album Hey Congress, out now.
Visit irregularorder.com →Background, education, travel, and influences.
Matthew Chervenak is an entrepreneur dedicated to strengthening liberal democracy and advancing science. He founded and leads Legis1 and AllCiv, which improve political knowledge, discourse, and engagement for citizens, professionals, and public officials. He founded and leads AllSci, which reframes the creation, utilization, and measurement of scientific knowledge. He is founder and president of the Sunwater Institute, a nonprofit think tank advancing fundamental ideas for improving liberal democratic institutions. He is a founder and General Partner of Sunwater Capital, an investment firm.
Mr. Chervenak writes and speaks on the US Congress, US democratic and civic institutions, scientific knowledge, biotechnology, and US-China relations. He writes and performs music and cofounded Irregular Order, a band celebrating the US Congress. He hosted a YouTube series on how the US Congress can improve its institutional performance.
Previously, Mr. Chervenak founded GBI, a data and analytics company serving the global pharmaceutical and biotechnology industries, which he led for two decades before its acquisition in 2023. His earlier career included strategy consulting and neuroscience research.
All but Alaska, North Dakota, and Washington.
Businesses, nonprofits, and products I have worked on.
Nonpartisan civic news and tools to power self-government.
Visit Platform →
Professional news, data, and analytics covering Congress, State legislatures, and elections.
Visit Platform →
Explore, publish, and peer review science.
Explore Platform →
Canonical data, ontologies, and APIs focused on US politics, global science, and global pharmaceuticals.
Visit Site →
Nonprofit, nonpartisan think tank with a mission to strengthen the foundations of liberal democracy through interdisciplinary science, technology, and open dialogue.
Explore Our Work →
Investment firm with holdings in real estate, healthcare, and data businesses.
Visit Site →Pharmaceutical and biotech intelligence, founded in 2002 and acquired in 2023.
A neighborhood newspaper of local news and stories.
Collection of my coauthored and solo work.
Co-authored with Brandice Canes-Wrone of Stanford’s Hoover Institution. Argues that the 119th House should rewrite its rules and procedures so committees and members have reason to invest in lawmaking, drawing on the Revitalizing the House task force recommendations — among them a “Guaranteed Regular Order” procedure guaranteeing each standing committee a floor vote on one major bill a year.
Read in The Hill →Co-authored with the Hoover Institution's Center for Revitalizing American Institutions. A bipartisan task force of former members of Congress, staffers, and scholars recommending reforms to House rules and procedures to re-empower individual members and committees in lawmaking.
Read Report →Co-authored with Ani Harutyunyan, Mark Schankerman, William Matcham, and Nishant Shrestha for the Sunwater Institute. Using three distinct methodologies, the report finds that the USPTO grants invalid patents at a low rate (under 9%) while valid claims are rejected far more often, challenging the prevailing narrative of a patent quality crisis.
Read Report →Co-authored with Matthew I. Jones and Nicholas A. Christakis. Examines the trade-offs of bundled voting versus issue-by-issue decision-making, finding that while bundling generally yields positive outcomes, it can easily produce results opposite to the majority's preferences on individual issues.
View on arXiv →Co-authored with Ani Harutyunyan and Mark Cohen for the Sunwater Institute. Examines existing indices for measuring intellectual property rights across countries, identifies critical gaps in current measurement methodologies, and proposes a novel approach evaluating real-world IP outcomes rather than inputs.
Read Report →Regular contributions to international publications about China's pharmaceutical and biotechnology sectors, providing insights on industry trends and developments.
Analysis of China's transition toward a more innovation-based pharmaceutical industry, examining the country's low-cost skilled workforce, strong life-science research track record, and entrepreneurial culture.
View on PubMed →Co-authored with Sax, Kays, Salamon, Xu, and Piatigorsky at the National Eye Institute, NIH. Examined the role of light exposure and eyelid opening in the up-regulation of transketolase gene expression during corneal maturation in mice.
View on PubMed →Co-authored with Sax and Piatigorsky at the National Eye Institute, NIH. Cloned and characterized the mouse TKT gene, finding evidence that oxidative stress may play a role in regulating this gene in the cornea.
View on PubMed →Original music about the U.S. Congress.
A Washington, D.C. band with one subject: Capitol Hill. Original songs about committees, cloture, horse-trading, and the human stakes of a singular institution, written and performed with Lee Drutman. Debut album Hey Congress, seven songs, released October 15, 2026.
Visit irregularorder.com →For ventures, research, or creative work.